CymitQuimica logo
Apoptose

Apoptose

Les inhibiteurs de l'apoptose sont des composés qui empêchent ou retardent le processus de mort cellulaire programmée, connu sous le nom d'apoptose. Ces inhibiteurs sont essentiels pour étudier les mécanismes de survie cellulaire et sont utilisés pour enquêter sur les maladies où l'apoptose est dysrégulée, telles que le cancer, les troubles neurodégénératifs et les maladies auto-immunes. En modulant l'apoptose, ces inhibiteurs peuvent aider au développement de thérapies visant à contrôler la mort cellulaire. Chez CymitQuimica, nous offrons une sélection complète d'inhibiteurs de l'apoptose de haute qualité pour soutenir vos recherches en biologie cellulaire, oncologie et domaines connexes.

Sous-catégories appartenant à la catégorie "Apoptose"

Affichez 6 plus de sous-catégories

6071 produits trouvés pour "Apoptose"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • Antiangiogenic agent 7

    CAS :
    Antiangiogenic agent 7 (Compound 1) induces apoptosis, elevates Reactive Oxygen Species (Reactive Oxygen Species), and inhibits the intracellular enzyme thioredoxin reductase. It exhibits anticancer activity with IC50 values ranging from 0.08 to 3.5 μM against cervical cancer cells (HeLa), prostate cancer cells (PC-3), and non-small cell lung cancer cells (A549). Additionally, Antiangiogenic agent 7 suppresses tumor growth in a mouse xenograft model.
    Formule :C24H26AuN3P2S
    Couleur et forme :Solid
    Masse moléculaire :647.46

    Ref: TM-T201574

    10mg
    À demander
    50mg
    À demander
  • (Rac)-Idroxioleic acid sodium

    CAS :
    (Rac)-Idroxioleic acid (2-Hydroxyoleic acid) sodium is a synthetic derivative of oleic acid (OA) that binds to the plasma membrane, altering lipid composition. This compound exhibits antitumor properties.
    Formule :C18H33NaO3
    Couleur et forme :Solid
    Masse moléculaire :320.44

    Ref: TM-T201603

    10mg
    À demander
    50mg
    À demander
  • Top/HDAC-IN-3

    CAS :
    Top/HDAC-IN-3 (Compound 31) is a dual inhibitor of Topoisomerase and HDAC with oral activity. It induces DNA damage by elevating reactive oxygen species (ROS) levels, consequently inhibiting the clonal formation and migration of cancer cells, and triggering apoptosis (Apoptosis) and cell cycle arrest. Top/HDAC-IN-3 demonstrates a significant antitumor effect in NSCLC models, exhibiting a tumor growth inhibition (TGI = 77.5%, 100 mg/kg) superior to that of the HDAC inhibitor SAHA and the combination of SAHA with the topoisomerase inhibitor Irinotecan.
    Formule :C24H25N3O5
    Couleur et forme :Solid
    Masse moléculaire :435.47

    Ref: TM-T201842

    10mg
    À demander
    50mg
    À demander
  • Laulimalide

    CAS :
    Microtubule stabilizer; halts cancer cell growth (IC50: 3-30 nM); arrests cells in prometaphase; prevents bipolar spindle formation.
    Formule :C30H42O7
    Couleur et forme :Solid
    Masse moléculaire :514.65

    Ref: TM-T37063

    1mg
    À demander
  • D18

    CAS :
    D18: Dual agonist for TLR7/8, boosts PD-L1, aids tumor sensitivity to PD-1/PD-L1 inhibitors, and is a cytotoxin for ADC HE-S2.
    Formule :C21H28N6
    Couleur et forme :Solid
    Masse moléculaire :364.49

    Ref: TM-T61390

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • HDAC-IN-37


    HDAC-IN-37 inhibits HDACs 1, 3, 8, & 6, induces histone acetylation, halts G1 to S phase, and triggers early apoptosis.
    Formule :C23H24ClN7O
    Couleur et forme :Solid
    Masse moléculaire :449.94

    Ref: TM-T62708

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • Anticancer agent 44


    Anticancer agent 44 induces apoptosis, is selective, cytotoxic to cancer cells, and minimally toxic to human lymphocytes.
    Formule :C22H13Cl2N3O5S2
    Couleur et forme :Solid
    Masse moléculaire :534.39

    Ref: TM-T63759

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • ZLMT-12


    ZLMT-12: tacrine derivative, inhibits CDK2/CDK9, weak on AChE/BuChE, anti-proliferative, low toxicity, blocks S/G2/M phase, induces apoptosis.
    Formule :C26H31ClN6O
    Couleur et forme :Solid
    Masse moléculaire :479.02

    Ref: TM-T63144

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • Topo I/COX-2-IN-1


    Topo I/COX-2-IN-1: potent dual inhibitor; IC50 0.24μM (COX-2), 4.42μM (Topo I); anti-cancer; induces apoptosis, halts migration.
    Formule :C21H18ClFN2O3
    Couleur et forme :Solid
    Masse moléculaire :400.83

    Ref: TM-T61939

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • MAPK-IN-5

    CAS :
    MAPK-IN-5 is a potent inhibitor of MAPK, with an IC50 value of 1.35 μM in HeLa cells. It induces ROS-mediated DNA damage and mitochondrial apoptosis (apoptosis) via the MAPK pathway. MAPK-IN-5 significantly inhibits colony formation in HeLa cells, reduces viable cell numbers, suppresses cell migration, and arrests the cell cycle at the G2/M phase. It is applicable in cervical cancer research.
    Formule :C30H29F3N6O4
    Couleur et forme :Solid
    Masse moléculaire :594.58

    Ref: TM-T211815

    10mg
    À demander
    50mg
    À demander
  • HI042

    CAS :
    HI042 is an FMS-like tyrosine kinase 3 (FLT3) inhibitor, showing an IC50 value of 0.62 μM for MOLM-13 cells, 0.33 μM for MV4-11 cells, and 0.89 μM for OCI-AML3 cells. It selectively reduces the survival rate of FLT3-internal tandem duplication (FLT3-ITD) positive cell lines, induces apoptosis, disrupts cell cycle progression, and diminishes colony-forming ability. HI042 is applicable for acute myeloid leukemia (AML) research.
    Formule :C14H11N3O3S
    Couleur et forme :Solid
    Masse moléculaire :301.32

    Ref: TM-T212451

    10mg
    À demander
    50mg
    À demander
  • NPB-1575

    CAS :
    NPB-1575 is a potent, orally active anti-inflammatory agent capable of crossing the blood-brain barrier. It mitigates neuroinflammation and resists ferroptosis by activating IRS2/Nrf2/NF-κB. NPB-1575 protects against cerebral ischemic injury and improves neurological function outcomes, making it suitable for research in focal ischemic stroke.
    Formule :C19H22O4
    Couleur et forme :Solid
    Masse moléculaire :314.38

    Ref: TM-T210796

    10mg
    À demander
    50mg
    À demander
  • Flonoltinib sulfate

    CAS :
    Flonoltinib maleate is an orally active dual inhibitor of JAK2/FLT3, with IC50 values of 0.7 nM for JAK2, 4 nM for FLT3, 26 nM for JAK1, and 39 nM for JAK3. It exhibits anticancer properties.
    Formule :C25H36FN7O5S
    Couleur et forme :Solid
    Masse moléculaire :565.661

    Ref: TM-T204180

    10mg
    À demander
    50mg
    À demander
  • Lometrexol

    CAS :
    <p>Lometrexol (LY 264618) is an antifolate that inhibits GARFT, blocks purine synthesis, induces apoptosis, and has anticancer properties.</p>
    Formule :C21H25N5O6
    Degré de pureté :97.76% - 99.56%
    Couleur et forme :Solid
    Masse moléculaire :443.45

    Ref: TM-T15826

    1mg
    88,00€
    5mg
    188,00€
    10mg
    311,00€
    25mg
    533,00€
    50mg
    787,00€
    100mg
    1.093,00€
    200mg
    1.454,00€
  • Zharp1-211

    CAS :
    Zharp1-211 is a RIPK3 inhibitor,reduces JAK/ stat1-mediated chemokines and MHC class II molecules in IECs, (GVHD) for gastrointestinal inflammation.
    Formule :C24H25N5O4
    Degré de pureté :99.71%
    Couleur et forme :Solid
    Masse moléculaire :447.49

    Ref: TM-T87664

    1mg
    87,00€
    5mg
    183,00€
    10mg
    283,00€
    25mg
    562,00€
    50mg
    873,00€
    100mg
    1.311,00€
    200mg
    1.768,00€
    1mL*10mM (DMSO)
    202,00€
  • Vatalanib hydrochloride

    CAS :
    Vatalanib hydrochloride (PTK787 hydrochloride) is an orally available and highly potent tyrosine kinase (VEGF) inhibitor that reduces the number and size of Aβ plaques in the cortex of 5xFAD mice, which may be useful in the study of Alzheimer's disease and cancer.
    Formule :C20H16Cl2N4
    Degré de pureté :99.7%
    Couleur et forme :Solid
    Masse moléculaire :383.27

    Ref: TM-T87609

    1mg
    140,00€
    5mg
    335,00€
    10mg
    502,00€
    25mg
    810,00€
    50mg
    1.111,00€
    100mg
    1.501,00€
    200mg
    2.023,00€
  • BCL6-IN-3

    CAS :
    BCL6-IN-3: potent BCL6 inhibitor, 70 nM GI50 in SU-DHL4, affects cell functions, antitumor.
    Formule :C24H31ClF2N6O2
    Degré de pureté :98.17%
    Couleur et forme :Solid
    Masse moléculaire :508.99

    Ref: TM-T10487

    1mg
    115,00€
    5mg
    255,00€
    10mg
    375,00€
    25mg
    562,00€
    50mg
    787,00€
    100mg
    1.074,00€
    500mg
    À demander
    1mL*10mM (DMSO)
    391,00€
  • HC-5404

    CAS :
    HC-5404 is a potent and selective PERK inhibitor, blocking the activation of the PERK pathway, anti-tumor effects, advanced solid tumors and renal cell Cancer.
    Formule :C24H24F2N4O3
    Degré de pureté :99.33%
    Couleur et forme :Solid
    Masse moléculaire :454.47

    Ref: TM-T86545

    1mg
    170,00€
    5mg
    426,00€
    10mg
    615,00€
    25mg
    938,00€
    50mg
    1.293,00€
  • UH15-38

    CAS :
    UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.
    Formule :C26H27N5O2
    Degré de pureté :99.85%
    Couleur et forme :Solid
    Masse moléculaire :441.53

    Ref: TM-T88101

    1mg
    120,00€
    5mg
    283,00€
    10mg
    472,00€
    25mg
    944,00€
    50mg
    1.510,00€
    100mg
    2.422,00€
  • Milademetan

    CAS :
    Milademetan (DS-3032), an MDM2 inhibitor, exhibits antitumor activity, induces G1 cell cycle arrest and apoptosis, and can be used to study solid tumors.
    Formule :C30H34Cl2FN5O4
    Degré de pureté :>99.99%
    Couleur et forme :Solid
    Masse moléculaire :618.53

    Ref: TM-T12040

    1mg
    87,00€
    5mg
    170,00€
    10mg
    274,00€
    25mg
    518,00€
    50mg
    847,00€
    100mg
    1.454,00€
    1mL*10mM (DMSO)
    234,00€